To assess the feasibility, efficacy and safety of Vertica® - Ohh-Med's RF device for home use, a pilot clinical study was conducted at the Neuro-urology unit, Rambam Healthcare Campus, Israel. 28 men having ED for at least six months participated in the study, with the final result being that of 85% of the participants experienced increased erectile function.
A follow-up study at 6 months after the last treatment illustrated the lasting effect of the Vertica treatment.
During the study, participants received a total of 12 treatments with the Vertica® device that included 2 treatments/week during the first 4 weeks (8 sessions in total) followed by 1 treatment/week for another 4 weeks (4 sessions in total). Treatments were self-conducted by the participants following detailed instructions.
The successful outcome consisted of positive changes in subjective and objective measures of erectile function, achieved without any adverse events. Outcome measures of success consisted of positive changes in subjective and objective measures of erectile function, achieved without adverse events.
The results demonstrated a significant improvement and enhancement of penile erections.
Normal spontaneous erections were achieved following treatment confirming that treatment with Vertica® enables the restoration of spontaneous sexual activity.
The treatment was safe, with no side effects or adverse events.
Illustrates that RF therapy affects the rehabilitation and enhancement of erectile function.